Mixed results: Study finds potential link between infant acid-suppressants and celiac disease
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Pharma News
Insomnia and sleep medication use connected to disability in older adults
Insomnia is a significant health and quality of life concern for older adults, with up to half of all adults...
Scientists achieve record-breaking growth in miniature, functional liver models
While organoids aim to mimic human organs, the liver's repertoire of complex functions - and thus the energy it needs...
Why people with mental health issues have ‘Starved in Jail.’ A journalist investigates
Why people with mental health issues have 'Starved in Jail.' A journalist investigates New Yorker writer Sarah Stillman found dozens...
FDA approves Click’s digital therapeutic for episodic migraine
More than 37 million adults in the US are affected by migraine The US Food and Drug Administration (FDA) has...
Aidan Synnott
Oncodesign Services has appointed Aidan Synnott as CEO Oncodesign Services has announced the appointment of Aidan Synnott as its new...
As a trans man, there’s nothing more gender affirming than being called “bossman” in the kebab shop.
You've been blocked by network security.To continue, log in to your Reddit account or use your developer tokenIf you think...
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular...
Leqembi approved as first treatment to slow early Alzheimer’s progression
European Commission grants authorisation for Eisai and Biogen therapy The European Commission has granted marketing authorisation for Leqembi (lecanemab), making...
An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as...
Potential treatment for Parkinson's using investigational cell therapy shows early promise
A stem cell-based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for...
We’re on the verge of a universal allergy cure
If you’re bothered by allergies every spring, you may pop a Benadryl or Claritin most mornings to make the days...
Researchers develop an LSD analogue with potential for treating schizophrenia
University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic...
UK clinical trials regulations signed into law
Major update aims to accelerate research and strengthen patient safety New UK clinical trials regulations have been signed into law,...
New test prototype for monitoring MGUS patients funded
Birmingham researchers to make MGUS monitoring more efficient Birmingham researchers have received £230k from Cancer Research Horizons to develop a...
The gut health benefits of sauerkraut
Is sauerkraut more than just a tangy topping? A new University of California, Davis, study published in Applied and Environmental...
Senator John Fetterman explains how GLP-1 drugs changed his life
A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity...
Drug pollution in water is making salmon take more risks
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Potential Alzheimer's disease therapeutic target identified in brain immune cells
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its...
Drug pollution alters salmon migration
In the largest study of its kind to date, a team of international researchers has investigated how pharmaceutical pollution affects...
